Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair

Journal of Orthopaedic Research

Volumn 29, Issue 7, 2011, Pages 1064-1069

  Shinohara, Kentaro ^a   Greenfield, Stephen ^b   Pan, Hui ^a   Vasanji, Amit ^a   Kumagai, Ken ^c   Midura, Ronald J ^a   Kiedrowski, Matthew ^a   Penn, Marc S ^a   Muschler, George F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

fracture; MCP 3; parabiosis; SDF 1; stem cell

Indexed keywords

COLLAGEN; GREEN FLUORESCENT PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 3; STROMAL CELL DERIVED FACTOR 1; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CALLUS; CELL COUNT; CELL HOMING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FIBULA; FRACTURE; GENETIC TRANSFECTION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOTOMY; PARABIOSIS; PRIORITY JOURNAL; STROMA CELL; TISSUE REPAIR; WILD TYPE;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL7; CHEMOKINE CXCL12; FEMALE; FRACTURE HEALING; FRACTURES, BONE; GREEN FLUORESCENT PROTEINS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOCYTES;

EID: 79955898007     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21374     Document Type: Article

References (26)

1. Carano RA, Filvaroff EH,. 2003. Angiogenesis and bone repair. Drug Discov Today 8: 980-989. (Pubitemid 37474243)
2. Einhorn TA,. 1998. The cell and molecular biology of fracture healing. Clin Orthop Relat Res S7-S21.
3. Shirley D, Marsh D, Jordan G, et al. 2005. Systemic recruitment of osteoblastic cells in fracture healing. J Orthop Res 23: 1013-1021. (Pubitemid 41245423)
4. Kuznetsov SA, Mankani MH, Gronthos S, et al. 2001. Circulating skeletal stem cells. J Cell Biol 153: 1133-1140.
5. Roufosse CA, Direkze NC, Otto WR, et al. 2004. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36: 585-597. (Pubitemid 38316816)
6. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, et al. 2005. Circulating osteoblast-lineage cells in humans. N Engl J Med 352: 1959-1966. (Pubitemid 40638366)
7. Khosla S, Eghbali-Fatourechi GZ,. 2006. Circulating cells with osteogenic potential. Ann NY Acad Sci 1068: 489-497. (Pubitemid 43824177)
8. Matsumoto T, Kuroda R, Mifune Y, et al. 2008. Circulating endothelial/skeletal progenitor cells for bone regeneration and healing. Bone 43: 434-439.
9. Kumagai K, Vasanji A, Drazba JA, et al. 2008. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 26: 165-175. (Pubitemid 351220134)
10. Otsuru S, Tamai K, Yamazaki T, et al. 2008. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 26: 223-234.
11. Levesque JP, Hendy J, Takamatsu Y, et al. 2003. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 111: 187-196. (Pubitemid 36105917)
12. Petit I, Szyper-Kravitz M, Nagler A, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3: 687-694. (Pubitemid 34752479)
13. Dar A, Goichberg P, Shinder V, et al. 2005. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 6: 1038-1046. (Pubitemid 41486189)
14. Carr AN, Howard BW, Yang HT, et al. 2006. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism. Cardiovasc Res 69: 925-935. (Pubitemid 43227991)
15. Yamaguchi J, Kusano KF, Masuo O, et al. 2003. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328. (Pubitemid 36314418)
16. Chen JL, Hunt P, McElvain M, et al. 1997. Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 15: 368-377. (Pubitemid 27413562)
17. Caplan AI, Bruder SP,. 2001. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7: 259-264. (Pubitemid 32545522)
18. Mahmood A, Lu D, Chopp M,. 2004. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 21: 33-39. (Pubitemid 38141800)
19. Schenk S, Mal N, Finan A, et al. 2007. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 25: 245-251. (Pubitemid 46052996)
20. Combadiere C, Ahuja SK, Van Damme J, et al. 1995. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem 270: 29671-29675. (Pubitemid 26001630)
21. Menten P, Wuyts A, Van Damme J,. 2001. Monocyte chemotactic protein-3. Eur Cytokine Netw 12: 554-560. (Pubitemid 34062141)
22. Kitaori T, Ito H, Schwarz EM, et al. 2009. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60: 813-823.
23. Askari AT, Unzek S, Popovic ZB, et al. 2003. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703. (Pubitemid 37101067)
24. Granero-Molto F, Weis JA, Miga MI, et al. 2009. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27: 1887-1898.
25. Ibiwoye MO, Powell KA, Grabiner MD, et al. 2004. Bone mass is preserved in a critical-sized osteotomy by low energy pulsed electromagnetic fields as quantitated by in vivo micro-computed tomography. J Orthop Res 22: 1086-1093. (Pubitemid 39145127)
26. Midura RJ, Ibiwoye MO, Powell KA, et al. 2005. Pulsed electromagnetic field treatments enhance the healing of fibular osteotomies. J Orthop Res 23: 1035-1046. (Pubitemid 41245426)